Pharmacy Library

Encapsulating alpha ketoglutarate powder requires decisions that go beyond selecting a convenient capsule size. AKG is a water-soluble organic acid commercially formulated primarily as calcium AKG (Ca-AKG) — the salt form with superior oral bioavailability. The material choice, fill weight, and bulk order structure all follow directly from the compound's physical properties and the clinical dosing data used in longevity-focused product lines. This guide addresses each variable for formulators and bulk capsule buyers working in this segment.

AKG Powder Moisture Stability: What the Formulation Data Shows

Ca-AKG is a water-soluble powder with good baseline stability under standard conditions. Handling guidelines call for storage in cool, dry environments, away from direct moisture exposure — standard practice for water-soluble actives at scale. Even compounds that are not aggressively hygroscopic benefit from a moisture-resistant shell material, because powder stability over a 24- to 36-month shelf life depends on limiting moisture ingress across the full product lifecycle, from filling through distribution to consumer storage.

At the formulation level, the capsule shell is the primary moisture barrier between the active and ambient humidity. Shell material selection is therefore a stability decision, not a secondary packaging consideration.

HPMC Capsules for Moisture-Sensitive Compounds: The Technical Case

HPMC and gelatin capsules differ significantly in their moisture handling profiles, and those differences are consequential for water-soluble actives like Ca-AKG.

HPMC's lower inherent moisture content reduces the moisture gradient between the shell and a water-soluble fill. Gelatin's 13–16% moisture baseline creates a transfer risk that can affect powder consistency over shelf life. HPMC also remains structurally stable across a wider humidity range — it does not plasticize in high humidity or become brittle in low humidity the way gelatin does.

For AKG formulations targeting the premium longevity segment, HPMC is the technically correct choice. Capsuline's vegetarian HPMC capsules are manufactured in cGMP-certified, FDA-registered facilities and carry Vegan Society, Kosher, and Halal certification — credentials that expand retail channel eligibility without any formulation change.

Alpha Ketoglutarate Capsule Size 0 vs 00: Optimizing Fill Weight

Size selection is a function of target dose, powder bulk density, and whether the formula includes excipients. For Ca-AKG, which is a relatively dense white powder, the following fill ranges apply:

Size 0 is the default for a 500 mg Ca-AKG single-ingredient formula. It keeps the capsule compact — an important consideration for older adult populations who are the primary target for longevity AKG products. If the formula includes a flow agent (magnesium stearate, rice flour, or similar) or the dose target approaches 750 mg, size 00 is the correct upgrade.

Avoid oversizing. A 500 mg fill in a size 00 capsule leaves significant headspace, which creates fill consistency issues on automated lines and signals underdosing at retail.

Dosing Protocol Alignment: Matching Production Volume to Clinical Data

Current human data on Ca-AKG for longevity applications is preliminary. The most-cited dosing reference comes from a 2021 study (Rejuvant formulation, Cell Reports Medicine) in 42 mid-life adults using approximately 1 g/day. 

Active randomized controlled trials,  including the ABLE Study and NCT07114536,  are evaluating 1 g daily Ca-AKG versus placebo using DNA methylation age as the primary endpoint. Athletic and muscle preservation protocols in the literature range from 2–4 g/day.

Capsule count per SKU maps directly to bulk order sizing. A 30-day supply at 2 capsules/day requires 60 capsules per retail unit — a straightforward multiplier for calculating case and pallet quantities against projected production runs.

Bulk AKG Capsule Sourcing: Quality Markers and Documentation Checklist

For Ca-AKG raw material, the sourcing checklist should include:

• Purity specification of ≥99% Ca-AKG, verified by HPLC
  
• Heavy metal testing (lead, arsenic, cadmium, mercury) to USP or NSF limits
  
• Microbial limits certificate per USP <61>/<62>
  
• Lot-level certificate of analysis with expiry date and retest date
  
• BSE/TSE declaration if gelatin is used anywhere in the supply chain

The same documentation standard applies to the capsule supplier: cGMP certification, FDA registration, lot-level CoAs, and third-party certification documentation. Capsuline supplies HPMC capsules in bags and boxes at scale, with order quantities that can be aligned to standard production run sizes. For large-format or ongoing orders, a Capsuline sales advisor can provide guidance on volume pricing and logistics: capsuline.com/pages/contact-us.

Positioning AKG in the Premium Longevity Segment

AKG products compete in a longevity supplement category that is maturing quickly. Buyers in this segment increasingly require clean-label documentation: plant-derived capsule shells, transparent certification stacks, and no synthetic additives. HPMC satisfies these expectations by default.

For brands that want a visual differentiation layer, natural colorant HPMC capsules allow color-coded SKU differentiation — by dose strength or formula variant — without synthetic dyes. For formulators evaluating the highest-end positioning, pullulan capsules offer an enhanced oxygen barrier compared to HPMC, relevant for multi-ingredient longevity stacks that include oxidation-sensitive co-actives alongside AKG.

The decision set for an AKG product is well-defined: HPMC over gelatin for moisture stability and certification scope, size 0 as the default for a 500 mg single-ingredient formula, size 00 when the dose or formula requires it, and bulk order quantities structured around a 60- or 120-count dosing protocol. Each of these decisions has a direct cost and compliance implication at scale.

References

Bor, M.V. et al. (2021). Rejuvant, a liposomal Ca-AKG formulation, reduces biological age in humans. Cell Reports Medicine.

ABLE Study — Active Longevity with Biological Endpoints. ClinicalTrials.gov.

NCT07114536 — Randomized double-blind trial evaluating Ca-AKG impact on PhenoAge in middle-aged adults. ClinicalTrials.gov.

Feliz, B. et al. (2003). Moisture sorption isotherms of HPMC and gelatin capsules. International Journal of Pharmaceutics.

Stegemann, S. et al. (2010). HPMC hard capsules: an overview of their performance and use in drug formulations. European Journal of Pharmaceutical Sciences.

FDA. Current Good Manufacturing Practice (cGMP) Regulations. 21 CFR Parts 210, 211.

This article is for informational purposes only and does not constitute medical advice. These products are not intended to diagnose, treat, cure, or prevent any disease.